Hydrocortisone 21-hemisuccinate (sodium salt) - CAS:125-04-2

您当前的位置：

Hydrocortisone 21-hemisuccinate (sodium salt) (Synonyms:氢化可的松琥珀酸钠;Hydrocortisone hemisuccinate sodium)

目录号 : KCM10835 CAS No. : 125-04-2 纯度 : ≥98%

Data Sheet SDS 产品使用指南

Hydrocortisone 21-hemisuccinate is a water-soluble form of the endogenous hormone cortisol. It can bind to glucocorticoid receptors, initiating the transcription of anti-inflammatory and immunosuppressive mediators and inhibiting proinflammatory cytokine activity (IC = 6.7 µM for IL-6). It is commonly used to supplement media for long-term epithelial or endothelial cell cultures and to differentiate pluripotent stem cells.

规格	价格	是否有货	数量
100mg		In-stock
500mg		In-stock
1g		In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Magnoloside B In-stock
House Dust Mite Extract, from D.pteronyssinus In-stock
Anti-IL11 Antibody (X203) In-stock
BI-765423 In-stock
InVivo Plus Anti-Mouse osteopontin/SPP1 Antibody (103D6) In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性

Hydrocortisone 21-hemisuccinate (sodium salt) is an orally active physiological glucocorticoid. Hydrocortisone 21-hemisuccinate (sodium salt) inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone 21-hemisuccinate (sodium salt) can be used for the research of ulcerative colitis (UC).

体外研究

Hydrocortisone 21-hemisuccinate (sodium salt) inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells.

Hydrocortisone 21-hemisuccinate (sodium salt) (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures.

体内研究

Hydrocortisone 21-hemisuccinate (sodium salt) (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice.

Animal Model:	Male Sprague-Dawley rats (200-220 g, 10-11 weeks) are induced colitis[1]
Dosage:	30 mg/kg
Administration:	P.o. twice daily for 5 days
Result:	Significantly decreased the disease activity index (DAI) scores and myeloperoxidase (MPO) activity compared to the 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) group. Increased the body weight.

分子式

C₂₅H₃₃O₈^.Na

分子量

484.51

CAS号

125-04-2

中文名称

氢化可的松琥珀酸钠

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

2-8°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据

In Vitro:

DMSO: 175 mg/mL (361.19 mM; Need ultrasonic)

H2O : 100 mg/mL (206.39 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.0639 mL	10.3197 mL	20.6394 mL
5 mM	0.4128 mL	2.0639 mL	4.1279 mL
10 mM	0.2064 mL	1.0320 mL	2.0639 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

纯度： ≥98%